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Abstract
Propensity score matching is commonly used to draw causal inference from obser-
vational survival data. However, there is no gold standard approach to analyze survival
data after propensity score matching, and variance estimation after matching is open
to debate. We derive the statistical properties of the propensity score matching esti-
mator of the marginal causal hazard ratio based on matching with replacement and a
fixed number of matches. We also propose a double-resampling technique for variance
estimation that takes into account the uncertainty due to propensity score estimation
prior to matching.
Keywords: Causal survival analysis; Martingale; Propensity score matching; Vari-
ance estimation; Double-resampling.
1 Introduction
For observational survival data, Cox proportional hazards modeling is the most common
approach to infer the association between treatment and survival outcome (Cox; 1972).
Following Rubin’s causal model, Hernán et al. (2000) and Robins et al. (2000) proposed the
marginal structural Cox proportional hazards model and inverse probability of treatment
weighting to estimate the causal effect of treatment on survival outcome.
Under the classical assumptions of no unmeasured confounding and positivity, the causal
effect of treatment is identifiable from the observed data. The seminal paper Rosenbaum
and Rubin (1983a) has demonstrated the central role of propensity score as the balancing
score, in the sense that balancing the propensity score can balance the observed covariates on
average. Researchers have proposed regression, propensity score-based weighting, stratifica-
tion, or matching estimators to adjust for confounding. In the context of survival analyses,
Chen and Tsiatis (2001) proposed a regression model approach to estimate the average
causal effect of restricted mean survival times. Xie and Liu (2005) developed the adjusted
Kaplan-Merier estimators of treatment-specific survival functions using inverse probability
weighting. Stürmer et al. (2005) demonstrated that different strategies are comparable to
adjust for confounding for estimating hazard ratios including inverse probability weighting,
propensity score matching, and stratification for a given dataset. Zhang and Schaubel (2012)
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combined Chen and Tsiatis (2001)’s regression method and the inverse probability weighted
Nelson-Aalen estimator resulting in a doubly robust estimator of the average causal effect of
restricted mean survival times. Tchetgen and Robins (2012) also proposed inverse probability
weighting and doubly robust methods for the causal hazard ratio.
The regression adjustment is susceptible to bias due to model misspecification; while
inverse probability weighting methods are unstable when the propensity score is close to zero
or one. Matching methods have been demonstrated to overcome these drawbacks and present
many practical advantages (Rubin; 2004; Stuart; 2010). Therefore, matching is widely used
in observational survival studies (Austin; 2007, 2008). However, there is no gold standard
approach to analyze survival data after propensity score matching with replacement, and
variance estimation is open to debate. Gayat et al. (2012) used the Cox proportional hazards
model and the robust variance estimator to infer the causal hazard ratio accounting for
the matched pairs. Therneau and Grambsch (2013) suggested fitting the Cox proportional
hazards model stratifying by the matched pairs. However, Austin (2013) pointed out that
this strategy may give biased results for the marginal hazard ratio due to non-collapsibility.
On the other hand, ignoring the matched nature is inappropriate (Austin; 2014). More
importantly, in practice, the propensity scores are usually estimated through a parametric
model in the first stage. Existing methods rarely incorporate the uncertainty prior to or in
the matching stage and restrict inference to the matched sample.
In this article, we consider propensity score matching for causal inference in the context
of survival analysis with two treatments. We focus on estimating the population average
causal hazard ratio, which is arguably the parameter of most interest given the widespread
use of the Cox model in practice. We note that paired matching may result in discarding
data when the numbers of treated and control individuals are not equal. Following Abadie
and Imbens (2006), we use propensity score matching as a tool for imputing unobserved
potential outcomes, i.e. counter-factual outcomes, for all individuals. Following most empir-
ical literature, we use a logistic regression model to estimate the propensity score function.
Because the propensity score function is estimated prior to matching, it is necessary to ac-
count for the uncertainty due to parameter estimation. Due to the non-smooth nature of
matching, our derivation is based on the technique developed by Andreou and Werker (2012),
which offers a general approach for deriving the limiting distribution of statistics that in-
volve estimated nuisance parameters. This technique has been successfully used in Abadie
and Imbens (2016) for the matching estimators of the average causal effects in a continuous
outcome context. We extend their results to the matching estimator in the survival outcome
context. This extension is not trivial, because the survival outcome is often right censored.
We utilize the martingale theory (Hall and Heyde; 1980) of the counting process to establish
the asymptotic distribution of the propensity score matching estimator of the causal hazard
ratio.
Lack of smoothness also makes the conventional replication methods invalid for variance
estimation for the propensity score matching estimator. The bootstrap method (Efron; 1979)
is a commonly used resampling approach that permits estimation of the sampling variability
of estimated parameters. There is some controversy surrounding variance estimation when
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estimating treatment effects in propensity score matched samples. Abadie and Imbens (2008)
demonstrated the failure of the bootstrap variance estimator for two-treatment matching
with replacement and a fixed number of matches. The main reason is that the bootstrap
sample does not preserve the distribution for the number of times that each individual is used
as a match. Yet, Austin and Small (2014) demonstrated by simulation that the bootstrap
has a good coverage property based on propensity score matching without replacement.
Adusumilli (2017) recently proposed a bootstrap inference for the propensity score matching
estimator for the continuous outcome, which improves the variance estimator based on the
asymptotic distribution described by Abadie and Imbens (2016). Accordingly, we propose a
new replication-based inference for the propensity score matching estimator in the survival
outcome context. Simulation demonstrates that the replication-based inference outperforms
Wald-type inference based on the asymptotic theory in finite samples.
2 Notation, Models and Assumptions
2.1 Potential outcomes
We use the potential outcomes framework (Rubin; 1974). We assume that the individuals are
random samples from a larger population. Let X ∈ Rd be a vector of baseline covariates.
Let W denote the treatment, which takes value in {0, 1}. Let T (ω) denote the potential
time to a clinical event had the individual received treatment ω. Let C(ω) be the time to
censoring had the individual received treatment ω. We assume non-informative censoring
under which C(ω) ⊥ T (ω), where ⊥ means “independent of”. The full set of variables is
F = (X,W, T (0), T (1), C(0), C(1)).
2.2 Marginal structural Cox proportional hazards model
For comparing two treatments, we consider the ideal case where we can observe F for each
individual. We define the causal parameter
λω(t) = lim
δt→0
1
δt
P
(
t ≤ T (ω) < t+ δt | T (ω) ≥ t)
as the hazard rate of failing at time t for a population of patients had they received treatment
ω. We define U (ω) = min(T (ω), C(ω)) and ∆(ω) = I(T (ω) ≤ C(ω)) to be the time to a clinical
event or censoring and the clinical event indicator, respectively, for an individual received
treatment ω. We also define the counting process N (ω)(t) = I(U (ω) ≤ t,∆(ω) = 1) and the
at-risk process Y (ω)(t) = I(U (ω) ≥ t).
Following Tchetgen and Robins (2012), we assume a causal Cox proportional hazards
model.
Definition 1 (Causal Cox Proportional Hazards Model). The structural model for compar-
ing treatments is
λω(t) = λ0(t) exp (β0W ) , (1)
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where λ0(t) is the population hazard rate if all individuals had treatment ω = 0.
This is a causal model, because it compares the outcome under different treatments in the
same group of individuals, i.e., the population of all individuals. The parameter β describes
the relative hazard of having a clinical event if all individuals received treatment ω = 1
compared to if all individuals received treatment ω = 0.
2.3 Observed data and the no unmeasured confounding assumption
The observed data are summarized as Oi = {Xi,Wi, Ui = min(Ti, Ci),∆i = I(Ti ≤ Ci)}, for
i = 1, . . . , n, where Xi is a vector of baseline covariates, Wi is the actual treatment, Ti is the
time to a clinical event, Ci is the observed censoring time, Ui is the time to a clinical event
or censoring, ∆i is the clinical event indicator, We now define the observed data counting
process as Ni(t) = I(Ui ≤ t,∆i = 1) and the at-risk process as Yi(t) = I(Ui ≥ t). Let
e(Xi) = P (Wi = 1|Xi) be the propensity score for individual i to receive treatment ω = 1.
We make the consistency assumption that links the observed data processes with the
potential outcome processes.
Assumption 1 (Consistency). Ti = T
(Wi)
i and Ci = C
(Wi)
i , or equivalently Ni(t) = N
(Wi)
i (t)
and Yi(t) = Y
(Wi)
i (t) for all t.
In order to use the distribution of the observed data to estimate the parameters in
Model (1), we require the assumptions of unconfoundedness (also known as no unmeasured
confounding or treatment ignorability) and positivity (Robins; 2004).
Assumption 2 (Unconfoundedness). Wi ⊥ {T (0)i , T (1)i } | Xi .
Assumption 3 (Positivity). There exist positive constants c and c¯ such that with probability
1, 0 < c < e(Xi) < c¯ < 1.
3 Matching
If we were to observe all potential outcome processes, we can fit a Cox proportional hazards
model to the data {N (ω)i (t), Y (ω)i (t) : ω = 0, 1; i = 1, . . . , n} to obtain an estimator for the
causal log hazard ratio β0. However, the fundamental problem in the potential outcome
framework is that we can observe for a particular individual i, {N (ω)i (t), Y (ω)i (t)} with either
ω = 0 or ω = 1 but never both. From this point of view, causal inference is inherently a
missing data problem.
We use matching as a tool to impute the missing potential outcomes. We consider
matching with replacement with the number of matches fixed at one, ignoring ties. To be
precise, for individual i, the potential outcome process under Wi is the observed outcome
process (Ui,∆i) ; the potential outcome process under 1 − Wi is not observed but can be
imputed by the observed outcome process of the nearest individual with 1−Wi.
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Table 1: Imputed data structure: ki is the number of times individual i is used as a match.
Full Imputed Dataset Weighted Representation
index
index X W matched individual (U (0),∆(0)) (U (1),∆(1)) weights (U,∆)
1
√
1 m{0, e(X1)}
(
Um{0,e(X1)},∆m{0,e(X1)}
)
(U1,∆1) 1 + k1(1) (U1,∆1)
2
√
0 m{1, e(X2)} (U2,∆2)
(
Um{1,e(X2)},∆m{1,e(X2)}
)
1 + k2(0) (U2,∆2)
...
...
...
...
...
...
...
n
√
1 m{0, e(Xn)}
(
Um{0,e(Xn)},∆m{0,e(n)}
)
(Un,∆n) 1 + kn(1) (Un,∆n)
We first consider the case when the propensity score is known and matching is done based
on the true propensity score. Define the propensity score matching function m(ω, p) as the
index of the individual with treatment level ω that is closest to p in terms of the propensity
score values
m(ω, p) = arg min
j:Wj=ω
|e(Xj)− p|.
Without loss of generality, we use the Euclidean distance to determine neighbors; the dis-
cussion applies to other distances (Abadie and Imbens; 2006).
Define the imputed potential outcome as
(
U
∗(ω)
i ,∆
∗(ω)
i
)
=
{
(Ui,∆i) if Wi = ω,(
Um{ω,e(Xi)},∆m{ω,e(Xi)}
)
if Wi = 1− ω,
(2)
or equivalently the imputed potential outcome process as
{
N
∗(ω)
i (t), Y
∗(ω)
i (t)
}
=
{
{Ni(t), Yi(t)} if Wi = ω,{
Nm{ω,e(Xi)}(t), Ym{ω,e(Xi)}(t)
}
if Wi = 1− ω,
(3)
for ω = 0, 1. Table 1 presents the full imputed dataset. Let ki(Wi) be the number of
times that individual i is used as a match for the opposite treatment group. Then, the full
imputed dataset can be equivalently represented by a weighted observed dataset, where each
individual i is assigned with a weight 1 + ki(Wi), 1 is the weight for individual i, and ki(Wi)
is the weight individual i can represent for individuals in the opposite treatment group.
4 Estimating equations
Define Λ0(t) =
∫ t
0
λ0(v)dv as the cumulative hazard function at time t. In what follows, we
derive our estimators for β0 and Λ0(t), t ≥ 0.
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Based on the imputed dataset, the estimating functions for β0 and Λ0(t), t ≥ 0 are
n∑
i=1
1∑
ω=0
{
dN
∗(ω)
i (t)− dΛ0(t) exp(βω)Y ∗(ω)i (t)
}
, (4)
n∑
i=1
1∑
ω=0
∫ τ
0
ω
{
dN
∗(ω)
i (t)− dΛ0(t) exp(βω)Y ∗(ω)i (t)
}
, (5)
where
{
N
∗(ω)
i (t), Y
∗(ω)
i (t)
}
(ω = 0, 1) is defined in (3). We can also write (4) and (5) as
n∑
i=1
{1 + ki(Wi)} {dNi(t)− dΛ0(t) exp(βWi)Yi(t)} , (6)
n∑
i=1
{1 + ki(Wi)}
∫ τ
0
Wi {dNi(t)− dΛ0(t) exp(β)Yi(t)} . (7)
Setting (6) equal to zero, we can obtain the estimator for dΛ0(t) for fixed β as
dΛ̂0(t) =
∑n
i=1{1 + ki(Wi)}dNi(t)∑n
i=1{1 + ki(Wi)} exp(βWi)Yi(t)
. (8)
Substituting (8) into (7), we obtain the estimating equation to solve for β. Let
Q̂(β, t) =
n−1
∑n
j=1{1 + kj(Wj)}Wj exp(βWj)Yj(t)
n−1
∑n
j=1{1 + kj(Wj)} exp(βWj)Yj(t)
, (9)
then β̂ is the solution to the estimating equation
Sn(β) =
n∑
i=1
∫ τ
0
{1 + ki(Wi)}
{
Wi − Q̂(β, t)
}
dNi(t) = 0, (10)
which is the partial score equation for a proportional hazards model withWi as the covariate
and weights 1 + ki(Wi) for each individual i. Therefore, β̂ can be calculated by standard
software.
To present the asymptotic properties of β̂, we introduce more notation. Let p(ω | X) =
pr(W = ω | X),
Hi(ω) =
∫ τ
0
{ω −Q(t)}
{
dN
(ω)
i (t)− dΛ0(t) exp(β0ω)Y (ω)i (t)
}
, (11)
µH(ω,X) = E{H(ω) | X}, and σ2H(ω,X) = var{H(ω) | X}. We show in the supplementary
material that under regularity conditions Q̂(β0, t) converges in probability to
Q(β0, t) =
exp(β0)S
(1)(t)
S(0)(t) + exp(β0)S(1)(t)
, (12)
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uniformly over t ∈ [0, τ ] and that
n−1/2Sn(β0) = n−1/2
n∑
i=1
{1 + kθ0,i(Wi)}Hi(Wi) + op(1). (13)
Based on (13), we derive the asymptotic results for β̂.
Theorem 1. Under the regularity conditions presented in the supplementary material, with
the known propensity score,
n1/2(β̂ − β0)→ N (0, V1),
as n→∞, V1 = {A(β0)}−1VS{A(β0)}−1,
VS =
1∑
ω=0
E
[
σ2H{ω, e(X)}
{
3
2p(ω|X) −
p(ω|X)
2
}]
+ E
(
[µH{0, e(X)}+ µH{1, e(X)}]2
)
,
(14)
and
A(β0) = E
(∫ τ
0
 E {exp(β0)Y (1)(t)}
E
{
Y
(0)
j (t)
}
+ E
{
exp(β0)Y
(1)
j (t)
} − 1

× E
{
exp(β0)Y
(1)(t)
}
E
{
Y
(0)
j (t)
}
+ E
{
exp(β0)Y
(1)
j (t)
} 1∑
ω=0
dN (ω)(t)
)
. (15)
In observational data, the propensity score is often unknown and therefore has to be
estimated from the observed data. Following most of the empirical literature, we assume
that the propensity score follows a generalized linear model, e(XTi θ). We can then obtain
a consistent estimate θˆ. The matching procedure can be carried out with the estimated
propensity score e(XTi θˆ). We now denote ki(ω) to be kθˆ,i(ω) to reflect its dependence on the
estimate θˆ.
To summarize, the algorithm for developing a matching estimator for β0 when the propen-
sity score is unknown is the following.
Step 1. Using the data {(Xi,Wi) : i = 1, . . . , n}, fit a propensity score model, e.g. a logistic
regression model e(XTi θ) and obtain an estimate θˆ.
Step 2. Based on the estimated propensity scores, create an imputed dataset as in Ta-
ble 1, where the missing potential outcomes are imputed using the nearest neighbor
imputation.
Step 3. Create weights for each individual i as 1 + kθˆ,i(Wi), where kθˆ,i(Wi) be the number
of times that individual i is used as a match for the opposite treatment group based
on the estimated propensity score estimates.
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Step 4. Obtain estimator for β0 by solving (10) using the standard software; e.g., the
function “coxph” in R with the weighting argument.
We study the asymptotic properties of the estimator in the case when the matching
variable is the estimated propensity score. The technique we will use is based on Andreou
and Werker (2012), who proposed a unified approach to study the limiting distribution of
statistics with estimated nuisance parameters. This technique has been applied by Abadie
and Imbens (2016) to study the asymptotic distribution of the matching estimator based on
estimated propensity score in the context of causal inference.
Theorem 2. Under the regularity conditions presented in the supplementary material, with
the estimated propensity score,
n1/2(β̂ − β0)→ N (0, V2),
as n→∞, V2 = {A(β0)}−1V˜S{A(β0)}−1, V˜S = VS − cTIθ0c, where VS is defined in Theorem
1, Iθ0 is the Fisher information of θ0,
c = E
{[
cov {X,µH(1, X) | e(X)}
e(X)
+
cov {X,µH(0, X) | e(X)}
1− e(X)
]
e˙(XTθ0)
}
, (16)
and e˙(XTθ0) = de(XTθ0)/dθ.
Theorem 2 shows that matching based on the estimated propensity score improves the
efficiency of the matching estimator compared to matching based on the true propensity
score if it is known. This phenomenon is in line with that in the setting with a continuous
come (Abadie and Imbens; 2016).
Theorem 2 provides variance estimation based on approximation of the asymptotic vari-
ance formula. See the supplementary material. In the next section, we propose re-sampling
variance estimation that has a better finite-sample performance.
5 Resampling based inference
Abadie and Imbens (2008) demonstrated that the nonparametric bootstrap is invalid for
the matching estimator based on matching with replacement and with a fixed number of
matches. Otsu and Rai (2017) suggested resampling the matching estimator directly based
on its martingale residual terms, which only works for matching based on the full vector
of covariates. In order to reflect the uncertainty in the estimation of the propensity score,
Adusumilli (2017) proposed a hybrid bootstrap procedure by resampling treatment variables
and resampling the martingale residuals under both treatment conditions. This necessitates
imputation of the unobserved martingale residuals under the opposite treatment. We define
the martingale residuals as
r̂1i(θ) = µ̂H {0, e(XTθ)}+ µ̂H {1, e(XTθ)} − 0,
r̂2i(ω, θ) = Hi(ω)− µ̂H {ω, e(XTθ)} ,
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where µ̂H(ω, p) is obtained by a non-parametric regression estimation of Hi on e(XTi θ̂) among
individuals with Wi = ω. We propose a double-resampling procedure as follows.
Step 0. For individual i, find the secondary nearest neighbor matching function m(ω,Xi);
if Wi = ω, m(ω,Xi) = i, otherwise, m(ω,Xi) returns the index of the nearest neighbor
in the opposite treatment group, matching based on the full X, rather than on the
propensity score. The pair of potential residuals for individual i are
r̂∗2i(0, θ) =
{
r̂2i(0, θ) if Wi = 0,
r̂2m(0,Xi)(0, θ) if Wi = 1,
r̂∗2i(1, θ) =
{
r̂2m(0,Xi)(1, θ) if Wi = 0,
r̂2i(1, θ) if Wi = 1.
(17)
Moreover, we need to estimate the matching function kθ0,i(ω) for ω = 0, 1. For ω = Wi,
let k̂i(ω) = kθ̂,i; for ω = 1 − Wi, we use the following imputation strategy: create
quintiles based on e(XTi θ̂), identify the quintile individual i falls, randomly sample
one, say l, from that quintile with Wj = ω, and let k̂i(ω) = kθ̂,l.
Step 1. Generate the bootstrap treatment, W ∗i , i = 1, . . . , n, from
W ∗i =
{
0, with probability 1− e(XTi θˆ),
1, with probability e(XTi θˆ).
Step 2. Based on (W ∗i , Xi)ni=1, re-fit the propensity score model and obtain the replicate θ̂∗.
Step 3. Generate a sequence of independent and identically distributed random variables
(u∗1, . . . , u
∗
n) from u∗i ∼ N (0, 1) or a two-point discrete distribution
u∗i =
{
−
√
5−1
2
, with probability
√
5+1
2
√
5
,√
5+1
2
, with probability
√
5−1
2
√
5
.
Step 4. Define the new bootstrap residuals as
r̂∗H,i(θ) = r̂1i(θ) + {1 + kθ̂,i(W ∗i )}r̂2i(W ∗i , θ),
whose expectation over the probability distribution implied by Step 1, conditional on
the original data, is
R̂∗H(θ) =
1
n
n∑
j=1
[
r̂1j(θ) + e(X
Tθ){1 + kθ̂,i(1)}r̂2j(1, θ)
+ {1− e(XTθ)}{1 + kθ̂,i(0)}r̂2j(0, θ)
]
,
where kθ̂,i(ω) is imputed at Step 0. Re-center the bootstrap residuals and compute the
replicate of Sn(β0) as S∗n =
∑n
i=1
{
r̂∗H,i(θ̂
∗)− R̂∗H(θ̂∗)
}
u∗i .
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Step 5. Repeat Steps 1–4 for a large number B times and denote the bth replicate of Sn(β0)
as S∗(b)n . Construct the (1−α)% percentile bootstrap confidence interval for Sn(β0) as(
S∗n(α/2), S
∗
n(1−α/2)
)
, where S∗nq is the qth percentile of {S∗(1)n , . . . , S∗(B)n }.
We construct the (1−α)% confidence interval for β0 as
{
∂Sn(β̂)/∂β
}−1 (
S∗n(α/2), S
∗
n(1−α/2)
)
.
Remark. Here we provide some discussion to Step 0. Note that the secondary matching
procedure matches on the full set of covariates, rather than on the propensity scores. Doing
so preserves the conditional covariance in (16) between X and the error terms r̂2i, given the
propensity scores. This term reflects the improvement when using the estimated propensity
score. See Adusumilli (2017). We impute ki(ω) by drawing a value from the empirical
distribution of ki(Wi) in propensity score strata for Wi = ω to re-create the distribution of
ki(Wi).
6 Simulation
We conduct simulation studies to assess the finite sample performance of the proposed esti-
mators relative to existing estimators:
(i) the unadjusted estimator βˆnai, which is obtained by fitting the Cox proportional
hazards model with the treatment status as the only covariate and therefore is used to
demonstrate the degree of confounding bias;
(ii) the inverse probability weighting estimator βˆipw, where a weighted Cox proportional
hazards model was fitted with the treatment status as the only covariate, weighted by
the inverse of the probability of the actual treatment;
(iii) the regression estimator βˆreg, where the Cox proportional hazards model was fitted
with baseline covariates and treatment status as the covariates;
(iv) the propensity score matching estimator βˆpsm,0 based on the true propensity score;
(v) the proposed propensity score matching estimator βˆpsm based on estimated propen-
sity score.
These comparative estimators have been widely used in practice, which motivates us to
compare these estimators in our simulation study. For variance estimation of βˆnai, βˆipw,
and βˆreg, we consider the robust output from the standard software, denoted by Vˆnai, Vˆipw,
and Vˆreg. For inference based on βˆpsm, we construct Wald confidence interval based on
the empirical variance estimator and two bootstrap percentile confidence intervals with the
conventional bootstrap and the proposed double-resampling procedure.
We consider a sample size of n = 1000. Let Xi = (X1i, X2i) be a vector of baseline
covariates, where we generate Xki from exponential distribution with mean 1/λk with λk = 1
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for k = 1 and 2. We generate the treatment indicatorWi ∼Ber(pi), where pi = {1+exp(θ0+
θT1Xi)}−1. We generate two potential outcomes T (0)i and T (1)i according to Algorithm S1 that
are compatible with Model (1). The observed time to event is Ti = (1 −Wi)T (0)i + WiT (1)i .
We also generate the time to censoring Ci from a uniform distribution, so that 20% to 30%
of the event time is censored.
We consider simulation scenarios formed by crossing the following two factors:
1) degree of confounding ranging from weak, medium and strong by considering θ =
(θ0, θ
T
1 )
T ∈ {−2.0, 0.5, 0.5}, {−3.0, 1.2, 1.2}, and {−4.0, 2.0, 2.0}; see the supplementary
material for the distributions by the treatment group;
2) model specification of the propensity score model: Scenario (i) using a correct speci-
fication of the propensity score model; i.e., a logistic regression model with the linear
predictor θ0 + θT1Xi, and Scenario (ii) using a misspecification of the propensity score
model; i.e., a logistic regression model with the linear predictor θ0 + θT1X
1/2
i .
Table 2 shows the results when true β0 = 0. The results for β0 = −0.5 and β0 = 0.5 are
presented in the supplementary material. The unadjusted estimator βˆnai has severe bias and
thus barely captures β0, which becomes worse for stronger separation of propensity scores
between treatment groups. The inverse probability weighting estimator βˆipw greatly reduces
the bias; however, its variability is underestimated when two treatment groups are strongly
separated in propensity scores and the propensity score model is correctly specified, thus the
robust confidence interval from the standard software has some undercoverage issue in this
case. The bias of the regression estimator βˆreg is always much larger than the propensity
score based estimators. For all investigated simulation scenarios, βˆpsm possesses the small-
est bias and best coverage rate of 95% confidence intervals using the proposed asymptotic
variance estimation and double-resampling variance estimation, among all estimators under
comparison. On the other hand, using the standard software’s robust method always over-
estimates the variances of βˆpsm,0 and βˆpsm. Thus, our newly proposed variance estimation
approaches is apparently beneficial for making reliable inference. Simulations with a sample
size of n = 200 are included in the supplementary material. For the small sample cases, it
is noticed that the double-resampling method recovers the 95% confidence level better than
the asymptotic method.
7 An application
Non-small cell lung cancer (NSCLC) is the most commonly diagnosed lung cancer; typically,
around half the NSCLC patients receiving chemotherapy will receive additional treatment
in the post progression setting, i.e. second-line treatment setting, where “carboplatin +
paclitaxel" and “erlotinib" are two historically commonly used treatments; see Cui et al.
(2018). In this section, we use the IMS Health Oncology electronic medical record (EMR)
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Table 2: Simulation results: bias (×102) and variance (×103) of the point estimator of β0,
coverage (%) of 95% confidence intervals based on 1, 000 Monte Carlo samples with true
β0 = 0
Bias Var VE CR Bias Var VE CR Bias Var VE CR
Confounding level weak medium strong
Scenario (i) Correct specification of the propensity score model
βˆnai -31.9 7.2 6.7 3.2 -57.2 6.5 6.0 0.0 -69.3 6.0 5.8 0.0
βˆipw -0.3 7.9 8.5 96.1 -0.9 12.5 13.5 96.4 -4.3 24.1 21.5 90.6
βˆreg 0.4 8.3 7.4 94.0 -5.2 9.4 8.5 90.9 -13.6 10.1 9.5 71.1
βˆpsm,0 -0.3 10.1 11.7 96.1 -0.8 14.1 17.7 96.9 -2.7 26.8 31.3 94.2
βˆpsm
software -0.3 10.3 11.6 96.3 -0.5 14.7 17.8 96.0 -2.8 26.9 31.3 94.0
asymp -0.3 10.3 9.7 93.7 -0.5 14.7 14.0 93.8 -2.8 26.9 26.5 92.1
naiveboot -0.3 10.3 9.1 95.9 -0.5 14.7 12.5 95.4 -2.8 26.9 22.1 94.5
double-rsp -0.3 10.3 10.7 95.2 -0.5 14.7 16.1 95.8 -2.8 26.9 35.0 97.0
Scenario (ii) Misspecification of the propensity score model
βˆnai -15.8 7.6 7.1 51.9 -35.1 6.8 6.3 0.8 -49.9 6.0 5.7 0.0
βˆipw -2.0 7.0 7.6 95.4 -3.4 7.1 7.9 94.3 -0.1 13.2 11.8 95.6
βˆreg -1.0 7.7 7.3 94.8 -2.2 7.8 7.0 92.9 -6.3 7.6 7.3 88.4
βˆpsm,0 -0.2 9.6 10.9 96.6 -0.5 10.2 11.9 96.7 -0.7 11.7 14.2 96.8
βˆpsm
software -0.3 9.5 10.8 96.6 -0.6 9.8 11.7 96.8 -0.4 11.2 13.9 96.3
asymp -0.3 9.5 9.2 94.6 -0.6 9.8 9.8 94.7 -0.4 11.2 10.9 93.3
naiveboot -0.3 9.5 8.9 97.3 -0.6 9.8 9.2 96.8 -0.4 11.2 10.1 95.8
double-rsp -0.3 9.5 10.3 96.0 -0.6 9.8 11.7 96.5 -0.4 11.2 13.9 95.5
Note: "Var" is the variance of point estimates of β0 across simulated datasets; "VE" is the
average variance estimation for the point estimators over simulations, thus VE minus Var
reflects the bias in estimated variance; "CR" is the empirical coverage rate of 95% confidence
intervals. Four types of variance estimates for βˆpsm were compared: "software", output from
the standard software; "asymp", the proposed asymptotic variance estimation; "naiveboot",
the naive nonparametric bootstrap; "double-rsp", the proposed double-resampling method.
data to conduct a comparative effectiveness analysis of the two treatments in the second-
line setting with the proposed causal inference of hazard ratio based on propensity score
matching estimator and other existing estimators mentioned in the previous section.
The EMR data is deidentified observational patient-level clinical data with demographic
and baseline clinical characteristics collected from medium and large community-based on-
cology practices across 50 states of the USA. The dataset used contains retrospective cohort
of 10,634 eligible patients at least 18 years old who received at least two lines of therapy,
from 1 January 2007 to 31 December 2014; see Cui et al. (2018) for details. The time from
the start date of second-line therapy to the death date was defined as overall survival. Pa-
tients alive at the end of the time period were censored at the end date of the dataset, and
patients with the time between last visit and the end of dataset shorter than a sufficient time
were censored at the date of last visit, where sufficient time is defined as twice the average
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time between visits in 3 month before the last visit. Missing data were classified into its
own category for each categorical variable; see de Rooij (2018). Among the eligible patients
in the dataset, 1241 patients were treated with carboplatin + paclitaxel, and 895 patients
received single-agent erlotinib as second-line therapy.
The propensity scores were estimated using a logistic regression model with predictors:
age at initiation of second-line therapy, gender, race, region, disease stage at initial diagnosis,
Eastern Cooperative Oncology Group performance status score at initiation of second-line
therapy, facility types of academic or community cancer center, year of index diagnosis,
and days from index diagnosis to initiation of second-line therapy, see Cui et al. (2018) for
details. To improve the overlapping in the covariate distribution for more credible matching,
see Yang et al. (2016), we applied Crump et al. (2009)’s trimming method to drop patients
with extremely high or low propensity scores, the remaining sample contains 1027 patients
receiving carboplatin + paclitaxel and 872 patients receiving erlotinib. We proceed with the
data of the remaining patients in the two cohorts for comparative effectiveness analysis on
the population represented after trimming.
Table 3 shows estimated log hazard ratio βˆ, point estimates and 95% confidence intervals
for the hazard ratio of “carboplatin + paclitaxel" to “erlotinib" based on the unadjusted esti-
mator βˆnai, the inverse probability weighting estimator βˆipw, the regression estimator βˆreg with
the robust variance estimation from the standard software for constructing Wald confidence
intervals. For the proposed inference based on propensity score matching estimator βˆpsm,
we constructed both Wald confidence interval based on the empirical asymptotic variance
estimator and bootstrap percentile confidence interval with the proposed double-resampling
method.
Table 3: Estimated β0 and hazard ratio of comparing “carboplatin + paclitaxel" to “er-
lotinib"
βˆ Estimated Hazard Ratio 95% Confidence Interval
Naive -0.127 0.880 (0.801, 0.968)
IPW -0.076 0.927 (0.836, 1.028)
REG -0.105 0.900 (0.814, 0.995)
PSM (asymptotic) -0.035 0.965 (0.853, 1.093)
PSM (resampling) -0.035 0.965 (0.843, 1.099)
All adjusted methods gave higher hazard ratio estimates than the unadjusted naive
method. The propensity score matching approach estimated that “carboplatin + paclitaxel"
reduces the hazard by around 3.5% versus “erlotinib", with both the 95% confidence inter-
vals based on the proposed asymptotic method and double-resampling method including 1
for hazard ratio, indicating insufficient evidence for a statistically significant difference at
0.05 level in the effectiveness comparison. Among the other adjusted approaches presented
in Table 3, another 95% confidence interval covering 1 for hazard ratio is based on inverse
probability weighting. The proposed asymptotic method and double-resampling method for
propensity score matching estimator provided wider intervals than other adjusted approaches
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in Table 3, while the double-resampling method seemed to be more conservative than the
asymptotic results in effectiveness comparison.
8 Discussion and future studies
We establish the statistical properties of the propensity score matching estimator of the
marginal causal hazard ratio based on matching with replacement and a fixed number of
matches. We also propose a double-resampling technique for variance estimation that takes
into account the uncertainty due to propensity score estimation prior to matching. Several
issues are worth discussing. First, although the literature has proposed flexible machine
learning methods for estimating the propensity score function, our development relies on a
parametric assumption, which enables to quantify the impact of propensity score estimation
on the matching estimator. Second, there may not be sufficient overlap in terms of distribu-
tion of covariates between treatment groups. Crump et al. (2009) and Yang and Ding (2018)
suggested trimming the propensity score beyond some thresholds. The criterion is based
on minimizing the asymptotic variance of continuous outcome. It would be interesting to
develop similar criteria to identify optimal overlap regions for the survival outcome. Third,
Yang et al. (2016) has developed the generalized propensity score matching for multiple
treatments for continuous outcomes. It is also of interest to extend our inference framework
to more than two treatment comparison for survival outcomes. Fourth, in our future work,
we will develop sensitivity analyses to no unmeasured confounding and methods to handle
missingness and informative censoring.
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Supplementary material
Supplementary material includes proof.
S1 Regularity conditions and Lemmas
In this section, we provide the regularity conditions and lemmas.
Assumption S1 (Regularity conditions). (i) X has a continuous distribution with a compact
support and a continuous density function; (ii) µH(ω, x) is Lipschitz-continuous in x; (iii)
E
(|Hi(ω)|2+δ|Wi = ω,Xi = x) is uniformly bounded over the support of X, for some δ > 0,
The regularity conditions are standard in the literature and are often assumed for tech-
nical convenience.
Let nω =
∑n
i=1 I(Wi = ω) be the number of individuals received treatment ω, and let
pω = pr(W = ω) > 0, for ω = 0, 1.
Lemma S1. Suppose that (W1, X1),...,(Wn, Xn) are independent and identically distributed,
where X is a scalar continuous variable with a bounded support. Suppose also that σ2H(ω, x)
is uniformly bounded over the support for X. Then, for a given ω,
1
nω
n∑
i=1
I(Wi = ω)σ
2
H(ω,Xi)ki(ω)→ E
{
σ2H(ω,Xi)
(
pω
1− pω
)1−2Di(ω)
| Wi = ω
}
,
and
1
nω
n∑
i=1
I(Wi = ω)σ
2
H(ω,Xi)ki(ω)
2 → E
{
σ2H(ω,Xi)
(
pω
1− pω
)1−2Di(ω)
| Wi = ω
}
+
3
2
E
[
σ2H(ω,Xi)
(
pω
1− pω
)2{1−2Di(ω)}
| Wi = ω
]
,
in probability, as n→∞.
Lemma S1 is Lemma A.11 in Abadie and Imbens (2012).
S2 Proof of the asymptotic unbiasedness of n−1Sn(β0)
This section includes three parts that follow the similar logic of proof. The first and the
second parts provide some results useful for later sections. The proof for the asymptotic
unbiasedness of n−1Sn(β0) is located in the third part.
For ω = 0, 1, define dM (ω)(t) = dN (ω)(t) − dΛ0(t) exp(β0ω)Y (ω)(t). From the stan-
dard theory for the counting process, dM (ω)(t) is a martingale process with respect to
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the population and its baseline hazard Λ0(t). Next we will prove that I(Wi = ω){1 +
ki(ω)} {dNi(t)− dΛ0(t) exp(β0ω)Yi(t)} is a martingale for the imputed pseudo-population
which means that imputed pseudo-population has similar covariates distribution with the
target population. First, we show that for ω = 0, 1,
n−1
n∑
i=1
I(Wi = ω){1 + ki(ω)} {dNi(t)− dΛ0(t) exp(β0ω)Yi(t)}
→ E {dN (ω)(t)− dΛ0(t) exp(β0ω)Y (ω)(t)} = E {dM (ω)(t)} , (S1)
as n → ∞. We show (S1) for ω = 1. The proof for ω = 0 is similar and therefore omitted.
We express (S1) for ω = 1 as
n−1
n∑
i=1
Wi{1 + ki(1)} {dNi(t)− dΛ0(t) exp(β0)Yi(t)} − E
{
dM (1)(t)
}
= n−1
n∑
i=1
Wi{1 + ki(1)}
{
dN
(1)
i (t)− dΛ0(t) exp(β0)Y (1)i (t)
}
− E {dM (1)(t)}
= n−1
n∑
i=1
Wi{1 + ki(1)}dM (1)i (t)− E
{
dM (1)(t)
}
= n−1
n∑
i=1
Wi{1 + ki(1)}
[
dM
(1)
i (t)− E
{
dM (1)(t) | e(Xi)
}]
+ n−1
n∑
i=1
(1−Wi)
[
E
{
dM (1)(t) | e(Xm{1,e(Xi)})
}− E {dM (1)(t) | e(Xi)}]
+ n−1
n∑
i=1
E
{
dM (1)(t) | e(Xi)
}− E {dM (1)(t)}
= T1 + T2 + T3,
where the second line follows by the consistent assumption, and
T1 = n
−1
n∑
i=1
Wi{1 + ki(1)}
[
dM
(1)
i (t)− E
{
dM (1)(t) | e(Xi)
}]
,
T2 = n
−1
n∑
i=1
(1−Wi)
[
E
{
dM (1)(t) | e(Xm{1,e(Xi)})
}− E {dM (1)(t) | e(Xi)}] , (S2)
T3 = n
−1
n∑
i=1
E
{
dM (1)(t) | e(Xi)
}− E {dM (1)(t)} .
Under Assumption S1, Abadie and Imbens (2006) showed that ki(1)δ is bounded almost
surely for any δ > 0, and the discrepancy due to matching is |Xm{1,e(Xi)}−Xi| = Op(n−1) for a
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scalar X. It follows that T1 is consistent for zero. Moreover, assuming that E
{
dM (1)(t) | p}
is Lipschiz continuous in p, T2 is consistent for zero. Lastly, by the strong law of large
numbers, T3 is consistent for zero. Therefore, (S1) follows.
Since n−1
∑n
i=1 I(Wi = ω)(1 + ki(ω))
{
ω − Qˆ(β0, t)
}
dM
(ω)
i (t) is bounded, by dominated
convergence theorem,
n−1Sn(β0) = n−1
1∑
ω=0
n∑
i=1
∫ ∞
0
I(Wi = ω){1 + ki(ω)}
{
ω − Qˆ(β0, t)
}
dM
(ω)
i (t) (S3)
→
1∑
ω=0
∫ ∞
0
{
ω − Qˆ(β0, t)
}
E
{
dM (ω)(t)
}
= 0. (S4)
S3 Proof for Theorem 1
Taylor expansion of Sn(β̂) = 0 around β0 leads to
0 = Sn(β̂) = Sn(β0) +
∂Sn(β˜)
∂βT
(β̂ − β0),
where β˜ is on the line segment between β̂ and β0. Assuming that n−1∂Sn(β˜)/∂βT is invertible,
we have
n1/2(βˆ − β0) =
{
n−1
∂Sn(β˜)
∂βT
}−1
n−1/2Sn(β0). (S5)
Under suitable regularity conditions, n−1∂Sn(β˜)/∂βT converges in probability to a positive-
definite matrixA(β0). Then the reminder is to show the asymptotic distribution of n−1/2Sn(β0).
Theorem S1. Suppose Assumptions 1–3 and Assumption S1 hold. Then,
n−1/2Sn(β0)→ N (0, V S), (S6)
in distribution, as n→∞, where
V S =
1∑
ω=0
E
[
σ2H(ω,X)
{
3
2
1
p(ω | X) −
1
2
p(ω | X)
}]
+ E
[{µH(0, X) + µH(1, X)}2] . (S7)
Proof. We will show that n−1/2Sn(β0) can be expressed as a sum of n independent and
identically distributed random vectors plus a term that converges in probability to a zero
vector. By some algebra, we obtain
n∑
i=1
{1 + ki(Wi)}
{
Wi − Q̂(β0, t)
}
dΛ0(t) exp(β0Wi)Yi(t) = 0. (S8)
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Therefore, continuing with (S3), we obtain
n−1/2Sn(β0)
= n−1/2
n∑
i=1
{1 + ki(Wi)}
∫ τ
0
{
Wi − Q̂(β0, t)
}
dMi(t) (S9)
= n−1/2
n∑
i=1
{1 + ki(Wi)}
∫ τ
0
{
Wi − Q̂(β0, t)
}
{dNi(t)− dΛ0(t) exp(β0Wi)Yi(t)} (S10)
= n−1/2
n∑
i=1
{1 + ki(Wi)}
∫ τ
0
{Wi −Q(β0, t)}
{
dNi(t)− dΛ0(t)eβ0WiYi(t)
}
+ n−1/2
n∑
i=1
{1 + ki(Wi)}
∫ τ
0
{
Q(β0, t)− Q̂(β0, t)
}{
dNi(t)− dΛ0(t)eβ0WiYi(t)
}
, (S11)
where (S10) follows from (S8) . Under the standard regularity conditions in survival analysis,∫ τ
0
{
Q̂(β0, t)−Q(β0, t)
}[
n−1/2
n∑
i=1
(1 + ki)
{
dNi(t)− dΛ0(t)eβ0WiYi(t)
}]→ 0,
in probability, as n→∞. Therefore, (S11) becomes
n−1/2Sn(β0) = n−1/2
n∑
i=1
{1 + ki(Wi)}Hi(Wi) + op(1), (S12)
where Hi(ω) is defined in (11). Moreover,
E{Hi(Wi)} =
∫ τ
0
E [{Wi −Q(β0, t)} {dNi(t)− dΛ0(t) exp(β0Wi)Yi(t)}]
=
∫ τ
0
E
[
e(Xi) {1−Q(β0, t)} dM (1)(t)
]
−
∫ τ
0
E
[{1− e(Xi)}Q(β0, t)dM (0)(t)]
= 0,
where the last line follows by the martingale property for the potential outcome process.
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We write
n−1/2Sn(β0)
= n−1/2
{
Sn(β0)−
1∑
ω=0
n∑
i=1
µH(ω,Xi)
}
+ n−1/2
1∑
ω=0
n∑
i=1
µH(ω,Xi)
= n−1/2
[
n∑
i=1
{1 + ki(Wi)}Hi(Wi)−
n∑
i=1
1∑
ω=0
µH(ω,Xi)
]
+ n−1/2
1∑
ω=0
n∑
i=1
µH(ω,Xi)
=
1∑
ω=0
n−1/2
n∑
i=1
[
I(Wi = ω){1 + ki(ω)}{Hi(ω)− µH(ω,Xi)}
+ {1− I(Wi = ω)}{µH(ω,Xm(ω,Xi))− µH(ω,Xi)}+ µH(ω,Xi)
]
.
Similar to (S2), we have n−1/2
∑n
i=1{1 − I(Wi = ω)}{µH(ω,Xm(ω,Xi)) − µH(ω,Xi)} =
Op(n
−1/2) = op(1), for ω = 0, 1. Therefore, we can write
n−1/2Sn(β0) =
2n∑
l=1
ξn,l + op(1),
where
ξn,l =
{
n−1/2 {µH(0, Xl) + µH(1, Xl)} , 1 ≤ l ≤ n,
n−1/2 {1 + kl−n(Wl−n)} {Hl−n(Wl−n)− µH(Wl−n, Xl−n)} , n+ 1 ≤ l ≤ 2n.
Consider the σ-fields
Fn,l =
{
{W1, . . . ,Wl, X1, . . . , Xl} , 1 ≤ l ≤ n,
{W1, . . . ,Wn, X1, . . . , Xn, H1(W1), . . . , Hl−n(Wl−n)} , n+ 1 ≤ l ≤ 2n.
Then, for each n ≥ 1, {
l∑
j=1
ξn,j,Fn,l, 1 ≤ l ≤ 2n
}
is a martingale. Moreover, we evaluate
n∑
l=1
E
(
ξ2n,l | Fn,l−1
)→ E [{µH(0, X) + µH(1, X)}2] ,
and
2n∑
l=n+1
E
(
ξ2n,l|Fn,l−1
)
= n−1
n∑
i=1
1∑
ω=0
I(Wi = ω) {1 + ki(ω)}2 σ2H(ω,Xi)
→
1∑
ω=0
E
[
σ2H(ω,X)
{
3
2
1
p(ω | X) −
1
2
p(ω | X)
}]
,
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as n→∞. Apply the Central Limit Theorem for martingale arrays, (S6) follows.
To establish the result in Theorem 1, we replace X by e(X) as the matching variable;
therefore, (S6) holds for
VS =
1∑
ω=0
E
[
σ2H{ω, e(X)}
{
3
2
1
p(ω | X) −
1
2
p(ω | X)
}]
+ E
(
[µH{0, e(X)}+ µH{1, e(X)}]2
)
. (S13)
Combining (S5) and (S13), n1/2(β̂ − β0) is asymptotically normal with mean zero and
covariance matrix V1 = A(β0)−1VSA(β0)−1. This completes the proof for Theorem 1.
S4 Proof for Theorem 2
Theorem S2. Suppose that Assumptions 1–3 and Assumption S1 hold. Suppose that e(X)
follows a logistic regression model e(XTθ) with the true parameter value θ0. Let θˆ be the
maximum likelihood estimator for θ, and Iθ0 be the Fisher information matrix. Then, based
on matching on the estimated propensity score e(XTθˆ),
n−1/2Sn(β0)→ N
(
0, VS − cTI−1θ0 c
)
,
where
c = E
{[
cov {X,µH(1, X) | e(X)}
e(X)
+
cov {X,µH(0, X) | e(X)}
1− e(X)
]
e˙(XTθ0)
}
.
Proof. Let Zi = {Xi,Wi, Hi(Wi)}, and let L (θ | Z1, . . . , Zn) be the log likelihood function
of θ, i.e.,
L(θ | Z1, . . . , Zn) = log
[
n∏
i=1
e(XTi θ)
Wi{1− e(XTi θ)}1−Wi
]
=
n∑
i=1
[Wi log e(X
T
i θ) + (1−Wi) log{1− e(XTi θ)}] .
Following Abadie and Imbens (2016), we use the local experiment argument. Let θn =
θ0 + n
−1/2h, and P θn be the data distribution under e(XTθn). Also, we define
Λn(θ0 | θn) = L(θ0 | Z1, . . . , Zn)− L(θn | Z1, . . . , Zn). (S14)
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Under P θn , we can express n−1/2Sn(β0) = Dn(θn) + oP (1), where
Dn(θn) = n
−1/2
n∑
i=1
1∑
ω=0
[
I(Wi = ω) {1 + ki(ω)} [Hi(ω)− µH {ω, e(XTi θn)}]
+ µH {ω, e(XTi θn)}
]
.
We shall show that under P θn : Dn(θn)n1/2(θˆn − θn)
Λn(θ0 | θn)
→ N

 00
−hTIθ0h/2
 ,
 VS cTI−1θ0 −cThI−1θ0 c I−1θ0 h−hTc −hT hTIθ0h
 , (S15)
in distribution, as n → ∞. Then, by Le Cam’s third lemma (Le Cam and Yang; 1990),
n−1/2Sn(β0)→ N
(
0, VS − cTI−1θ0 c
)
in distribution, as n→∞.
To show (S15), denote
∆n(θ)=n
−1/2 ∂
∂θ
L(θ | Z1, . . . , Zn) = n−1/2
n∑
i=1
Xie˙(X
T
i θ)
Wi − e(XTi θ)
e(XTi θ){1− e(XTi θ)}
.
Then, under P θn :
∆n(θn)→ N (0, Iθ0), Iθ0 = E
[
e˙(XTθ)2XXT
e(XTθ){1− e(XTθ)}
]
,
in distribution, as n→∞.We also note that under P θn :
n1/2(θˆn − θn) = I−1θ0 ∆n(θn) + oP (1), (S16)
Λn(θ0 | θn) = −hT∆n(θn)− 1
2
hTIθ0h+ oP (1).
To show (S15), it suffices to show that(
Dn(θn)
∆n(θn)
)
→ N
{(
0
0
)
,
(
VS c
T
c Iθ0
)}
, (S17)
in distribution, as n → ∞. Toward this end, we consider the linear combination Ln =
z1Dn(θn) + z
T
2 ∆n(θn), for any z1 and z2. We write Ln =
∑3n
l=1 ξn,l, where
ξn,l =

z1n
−1/2∑1
ω=0 µH {ω, e(XTl θn)}
+zT2n
−1/2E {Xl | e(XTl θn)} e˙(XTi θn) Wi−e(X
T
i θn)
e(XTi θn){1−e(XTi θn)}
,
for 1 ≤ l ≤ n;
z1n
−1/2∑1
ω=0 I(Wl−n = ω) {1 + kl−n(ω)}
[
µH(ω,Xl−n)− µH
{
ω, e(XTl−nθn)
}]
+zT2n
−1/2 (Xl−n − E {Xl−n | e(XTl−nθn)}) e˙(XTl−nθn) Wl−n−e(XTl−nθn)e(XTl−nθn){1−e(XTl−nθn)} ,
for n+ 1 ≤ l ≤ 2n;
z1n
−1/2∑1
ω=0 I(Wl−2n = ω) {1 + kl−2n(ω)} {Hl−2n(Wl−2n)− µH(ω,Xl−2n)} ,
for 2n+ 1 ≤ l ≤ 3n.
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Consider σ−fields
Fn,l =

{W1, . . . ,Wl, XT1 θn, . . . , XTl θn} , 1 ≤ l ≤ n,
{W1, . . . ,Wn, XT1 θn, . . . , XTnθn, X1, . . . , Xl−n} , n+ 1 ≤ l ≤ 2n,
{W1, . . . ,Wn, X1, . . . , Xn, H1(W1), . . . , Hl−2n(Wl−2n)} , 2n+ 1 ≤ l ≤ 3n.
Then,
{∑l
j=1 ξn,j, Fn,i, 1 ≤ l ≤ 3n
}
is a martingale for each n ≥ 1. Under P θn ,
Ln → N (0, σ2L,1 + σ2L,2 + σ2L,3),
in distribution, as n→∞, where
σ2L,1 = z
2
1E
(
[µH {0, e(X)}+ µH {1, e(X)}]2
)
+ zT2E
[
E {X | e(X)}E {XT | e(X)} e˙(X
Tθ0)
2
e(X){1− e(X)}
]
z2,
σ2L,2 = z
2
1
1∑
ω=0
E
[
var {µH(ω,X) | e(X)}
{
3
2
1
p(ω | XTθ0) −
1
2
p(ω | XTθ0)
}]
+ 2zT2E
[
cov {X,µH(1, X) | e(X)} e˙(XTθ0)
e(X)
− cov {X,µH(0, X) | e(X)} e˙(X
Tθ0)
1− e(X)
]
z1
+ zT2E
[
var {X | e(X)} e˙(X
Tθ0)
2
e(X){1− e(X)}
]
z2,
and
σ2L,3 = z
2
1
1∑
ω=0
E
[
σ2H(ω,X) | e(X)
]{3
2
1
p(ω | X) +
1
2
p(ω | X)
}
.
Then, σ2L,1 + σ2L,2 + σ2L,3 = z21VS + zT2 I−1θ0 z2 + 2zT2 cz1. Thus, under P θn , (S17) follows. This
completes the proof for Theorem 2.
S5 Simulation
S5.1 An data-generating algorithm
We describe the algorithm for generating T (0) and T (1) that are congenial with Model (1) as
follows.
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Algorithm S1 for generating T (0) and T (1) that are congenial with Model (1)
Step 1. Generate T (0) from S(0)(t) = exp(−λ0t), where λ0 = 4.
Step 2. Generate u from Unif[0, 1], solve{
2∏
k=1
(
1− ηkt
λk
)}
exp [{η1X1 + η2X2 − λ0 exp(β0ω)} t]− 1 + u = 0
for t, where η1 = η2 = −1. Let T (1) be the solution t.
By Algorithm S1, T (1) given X follows
ST |W,X(t | W = 1, X) =
{
2∏
k=1
(
1− ηkt
λk
)}
exp [{η1X1 + η2X2 − λ0 exp(β0ω)} t] .
Under our parameter specification, we have (i) ST |W,X(t = 0 | W = 1, X = x) = 1, (ii)
ST |W,X(t = τ | W = 1, X = x) = 0, because of η1x1 + η2x2 − λ0 exp(β0ω) ≤ 0 , and (iii)
dST |W,X(t | W = 1, X = x)/dt ≤ 0, because of λ−11 + λ−12 ≤ min(λ0, λ0eβ0).
The marginal distribution of T (1) is
S(1)(t) =
∫
ST |W,X(t | W = 1, X = x)dF (x)
=
∫ { 2∏
k=1
(
1− ηkt
λk
)}
exp [{η1X1 + η2X2 − λ0 exp(β0)} t] dF (x)
=
{
S(0)(t)
}exp(β0ω)
.
Therefore, the marginal distributions of {T (0), T (1)} satisfy S(1)(t) = {S(0)(t)}exp(β0) .
S5.2 Illustration of propensity score distributions with weak, medium,
and strong separation
This section demonstrates the mentioned simulation settings of weak, medium, strong sep-
arations in the propensity scores between the two treatment groups. Density curves for the
true propensity scores of the two treatment groups are presented in dashed lines of W = 0
and in solid lines of W = 1 with weak, medium, strong separations respectively in Figure
S1.
S5.3 Additional simulation results
We provide additional simulation results. The simulation setting are the same as in §6 except
that β0 is set to be −0.5 and 0.5.
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Figure S1: Plots of weak separation, medium separation, and strong separation in distri-
butions of propensity score between treatment groups W = 0 and W = 1.
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Table S1: Simulation results: bias (×102) and variance (×103) of the point estimator of β0,
coverage (%) of 95% confidence intervals based on 1, 000 Monte Carlo samples with true
β0 = −0.5
Bias Var VE CR Bias Var VE CR Bias Var VE CR
Confounding level weak medium strong
Scenario (i) Correct specification of the propensity score model
βˆnai -35.4 7.7 7.5 2.4 -68.5 7.6 7.3 0.0 -87.9 7.6 7.5 0.0
βˆipw 0.7 8.1 9.4 97.1 -0.1 16.1 17.2 96.0 -5.3 35.0 28.7 89.4
βˆreg 5.4 9.6 8.9 88.9 -7.6 12.1 10.7 87.6 -25.8 13.0 12.1 34.7
βˆpsm,0 0.6 10.5 12.8 96.3 0.1 16.1 21.8 97.3 -2.4 34.2 43.2 93.3
βˆpsm
software 0.6 10.6 12.7 96.6 0.4 16.9 21.9 96.3 -2.6 33.5 43.3 93.7
asymp 0.6 10.6 10.3 94.0 0.4 16.9 15.8 92.8 -2.6 33.6 32.7 91.1
naiveboot 0.6 10.6 9.7 96.3 0.4 16.9 14.2 95.4 -2.6 33.6 27.7 94.3
double-rsp 0.6 10.6 11.6 95.1 0.4 16.9 18.7 95.0 -2.6 33.6 47.0 97.1
Scenario (ii) Misspecification of the propensity score model
βˆnai -16.6 8 7.6 51.5 -39.8 7.4 7.1 0.2 -60.7 7.0 6.9 0.0
βˆipw -1.2 7.1 8.2 95.9 -2.2 7.4 9.1 96.8 3.3 20.4 16.9 96.6
βˆreg 2.5 9.2 8.8 93.2 1.0 9.1 8.4 94.1 -10.0 9.2 9.0 81.6
βˆpsm,0 0.8 9.9 11.6 96.9 0.5 10.9 13.2 97.4 0.3 12.9 16.8 96.7
βˆpsm
software 0.8 9.6 11.5 97.4 0.4 10.6 12.9 97.2 0.6 12.5 16.4 96.7
asymp 0.8 9.6 9.6 95.4 0.4 10.6 10.6 93.8 0.6 12.5 12.2 93.5
naiveboot 0.8 9.6 9.3 97.6 0.4 10.6 9.9 97.0 0.6 12.5 11.2 96.6
double-rsp 0.8 9.6 10.9 96.3 0.4 10.6 12.8 96.2 0.6 12.5 15.8 95.8
Note: "Var" is the variance of point estimates of β0 across simulated datasets; "VE" is the
average variance estimation for the point estimators over simulations, thus VE minus Var
reflects the bias in estimated variance; "CR" is the empirical coverage rate of 95% confidence
intervals. Four types of variance estimates for βˆpsm were compared: "software", output from
the standard software; "asymp", the proposed asymptotic variance estimation; "naiveboot",
the naive nonparametric bootstrap; "double-rsp", the proposed double-resampling method.
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Table S2: Simulation results: bias (×102) and variance (×103) of the point estimator of β0,
coverage (%) of 95% confidence intervals based on 1, 000 Monte Carlo samples with true
β0 = 0.5
Bias Var VE CR Bias Var VE CR Bias Var VE CR
Confounding level weak medium strong
Scenario (i) Correct specification of the propensity score model
βˆnai -29.2 6.9 6.3 6.1 -49.9 5.9 5.4 0.0 -57.9 5.2 5.0 0.0
βˆipw -0.3 7.8 8.1 95.5 -0.7 10.7 11.7 96.5 -3.1 18.9 18.1 91.9
βˆreg -4.0 7.5 6.8 91.1 -6.0 8.4 7.7 87.9 -8.5 9 8.5 84.1
βˆpsm,0 -0.3 9.9 11.3 96.9 -0.6 13.0 15.9 96.8 -2.2 23.4 26.1 95.3
βˆpsm
software -0.3 10.2 11.3 96.6 -0.2 13.4 15.9 96.5 -2.2 23.1 26.0 95.6
asymp -0.3 10.2 9.6 94.1 -0.2 13.4 13.0 93.5 -2.2 23.2 23.3 91.8
naiveboot -0.3 10.2 9.1 95.9 -0.2 13.4 11.7 96.2 -2.2 23.2 19.4 94.9
double-rsp -0.3 10.2 10.4 95.4 -0.2 13.4 14.7 96.0 -2.2 23.2 29.7 95.7
Scenario (ii) Misspecification of the propensity score model
βˆnai -14.6 7.5 6.9 56.4 -31.5 6.4 5.9 1.6 -42.8 5.6 5.1 0.0
βˆipw -1.8 7.0 7.5 95.0 -3.5 6.9 7.5 94.1 -1.6 10.0 9.5 94.7
βˆreg -3.4 7.1 6.8 92.8 -5.6 7.1 6.5 88.1 -5.8 7.0 6.7 88.4
βˆpsm,0 -0.1 9.6 10.8 96.6 -0.5 9.8 11.4 96.4 -0.6 10.9 12.9 96.1
βˆpsm
software -0.2 9.4 10.7 96.2 -0.6 9.5 11.3 95.6 -0.3 10.4 12.7 96.2
asymp -0.2 9.4 9.2 95.0 -0.6 9.5 9.4 94.3 -0.3 10.4 10.2 93.8
naiveboot -0.2 9.4 8.9 97.6 -0.6 9.5 8.9 97.0 -0.3 10.4 9.5 96.1
double-rsp -0.2 9.4 10.1 95.1 -0.6 9.5 11.0 95.7 -0.3 10.4 12.7 95.9
Table S3: Simulation results: bias (×102) and variance (×103) of the point estimator of β0,
coverage (%) of 95% confidence intervals based on 200 Monte Carlo samples with true β0 = 0
Bias Var VE CR Bias Var VE CR Bias Var VE CR
Confounding level weak medium strong
Scenario (i) Correct specification of the propensity score model
βˆnai -31.6 33.2 33.8 61.3 -57.5 28.4 30.1 8.4 -69.9 28.9 29.0 1.5
βˆipw 0.4 37.5 42.6 95.2 -3.4 55.4 57.1 93.2 -10.5 91.5 75.1 87.3
βˆreg 1.4 38.9 37.5 94.2 -3.6 44.7 43.1 95.1 -11.9 55.3 47.8 89.7
βˆpsm,0 -0.3 48.7 54.2 95.7 -3.9 66.0 68.6 93.8 -9.1 117.1 94.4 89.4
βˆpsm
software 0.1 46.9 54.6 96.4 -3.8 67.2 69.5 93.1 -9.3 112.9 94.9 88.9
asymp 0.1 46.9 48.9 93.9 -3.8 67.2 65.4 91.5 -9.3 112.9 109.5 88.8
naiveboot 0.1 46.9 49.4 96.4 -3.8 67.2 63.1 94.4 -9.3 112.9 96.1 94.9
double-rsp 0.1 46.9 58.3 96.0 -3.8 67.2 74.6 93.7 -9.3 112.9 89.7 89.1
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Table S4: Simulation results: bias (×102) and variance (×103) of the point estimator of
β0, coverage (%) of 95% confidence intervals based on 200 Monte Carlo samples with true
β0 = −0.5
Bias Var VE CR Bias Var VE CR Bias Var VE CR
Confounding level weak medium strong
Scenario (i) Correct specification of the propensity score model
βˆnai -35.1 37.4 37.3 57.8 -69.0 35.1 36.3 3.6 -89.0 37.0 37.7 0.1
βˆipw 1.3 40.2 46.2 95.3 -3.8 65.0 66.3 94.4 -14.1 111.6 90.2 86.1
βˆreg 6.2 47.1 44.7 93.9 -5.0 56.9 53.2 94.3 -23.5 68.9 60.1 83.5
βˆpsm,0 0.5 50.1 57.8 95.6 -3.6 74.1 80.1 95.0 -10.6 141.8 118.0 88.7
βˆpsm
software 0.7 49.8 58.1 95.7 -3.7 75.0 81.2 93.9 -10.9 135.3 119.6 89.0
asymp 0.7 49.8 50.7 93.3 -3.7 75.0 73.5 92.1 -10.9 135.3 131.2 90.1
naiveboot 0.7 49.8 51.6 96.0 -3.7 75.0 70.7 94.9 -10.9 135.3 120.4 93.8
double-rsp 0.7 49.8 62.2 95.6 -3.7 75.0 85.9 94.7 -10.9 135.3 111.3 90.1
Table S5: Simulation results: bias (×102) and variance (×103) of the point estimator of
β0, coverage (%) of 95% confidence intervals based on 200 Monte Carlo samples with true
β0 = 0.5
Bias Var VE CR Bias Var VE CR Bias Var VE CR
Confounding level weak medium strong
Scenario (i) Correct specification of the propensity score model
βˆnai -28.8 32.8 32.2 64.7 -49.7 26.0 27.0 15.3 -57.9 25.0 25.2 4.0
βˆipw 0.7 37.2 41.7 95.7 -2.1 51.6 53.4 94.3 -7.2 82.3 69.1 89.5
βˆreg -2.5 37.0 34.8 93.2 -4.3 41.4 39.2 94.0 -6.7 50.6 43.2 91.9
βˆpsm,0 0.2 49.0 54.2 94.8 -2.5 63.2 65.1 94.2 -6.6 104.2 85.0 89.6
βˆpsm
software 0.6 47.0 54.6 96.3 -2.6 64.3 66.2 93.8 -7.0 100.7 85.0 91.4
asymp 0.6 47.0 49.1 94.8 -2.6 64.3 62.4 92.4 -7.0 100.7 97.1 90.3
naiveboot 0.6 47.0 49.5 96.4 -2.6 64.3 60.3 95.3 -7.0 100.7 85.4 95.2
double-rsp 0.6 47.0 57.8 96.3 -2.6 64.3 69.4 93.7 -7.0 100.7 78.7 89.6
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